Ceramide is responsible for the failure of compensatory nerve sprouting in apolipoprotein e knock-out mice

Journal of Neuroscience

Volumn 28, Issue 31, 2008, Pages 7891-7899

  Maysinger, Dusica ^a   Holmes, Michael ^b   Han, Xianlin ^c   Epand, Richard M ^b   Pertens, Evi ^b   Foerster, Anne ^b   Barlas, Cia ^b   Holtzman, David M ^c   Diamond, Jack ^b  

^a MCGILL UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Alzheimer's disease; ApoE; Axonal regeneration; Ceramide; Cutaneous nerve; Nerve growth factor; Nerve sprouting; NGF

Indexed keywords

APOLIPOPROTEIN E; CERAMIDE; FUMONISIN B1; NERVE GROWTH FACTOR; PROTEIN TYROSINE KINASE A; FUMONISIN;

AGING; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; KNOCKOUT MOUSE; MOUSE; NERVE FIBER REGENERATION; NERVE SPROUTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN; SPINAL GANGLION; WILD TYPE; ANIMAL; C57BL MOUSE; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; MALE; MOUSE MUTANT; NERVE CELL PLASTICITY; NERVE FIBER; NERVE REGENERATION; NERVOUS TISSUE; PHYSIOLOGY; SHEEP; TRANSGENIC MOUSE;

ANIMALS; APOLIPOPROTEINS E; AXONS; CERAMIDES; FUMONISINS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NERVE REGENERATION; NERVE TISSUE; NEURONAL PLASTICITY; SHEEP;

EID: 50349083801     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.1461-08.2008     Document Type: Article

References (64)

1. Anderson R, Barnes JC, Bliss TV, Cain DP, Cambon K, Davies HA, Errington ML, Fellows LA, Gray RA, Hoh T, Stewart M, Large CH, Higgins GA (1998) Behavioural, physiological and morphological analysis of a line of apolipoprotein E knockout mouse. Neuroscience 85:93-110.
2. Arévalo JC, Chao MV (2005) Axonal growth: where neurotrophins meet Wnts. Curr Opin Cell Biol 17:112-115.
3. Bedlack RS, Strittmatter WJ, Morgenlander JC (2000) Apolipoprotein E and neuromuscular disease: a critical review of the literature. Arch Neurol 57:1561-1565.
4. Bergman E, Fundin BT, Ulfhake B (1999) Effects of aging and axotomy on the expression of neurotrophin receptors in primary sensory neurons. J Comp Neurol 410:368-386.
5. Bhattacharyya A, Watson FL, Pomeroy SL, Zhang YZ, Stiles CD, Segal RA (2002) High-resolution imaging demonstrates dynein-based vesicular transport of activated Trk receptors. J Neurobiol 51:302-312.
6. Blöchl A, Blöchl R (2007) A cell-biological model of p75NTR signaling. J Neurochem 102:289-305.
7. Chalfant CE, Kishikawa K, Mumby MC, Kamibayashi C, Bielawska A, Hannun YA (1999) Long chain ceramides activate protein phosphatase-1 and protein phosphatase-2A. Activation is stereospecific and regulated by phosphatidic acid. J Biol Chem 274:20313-20317.
8. Champagne D, Rochford J, Poirier J (2005) Effect of apolipoprotein E deficiency on reactive sprouting in the dentate gyrus of the hippocampus following entorhinal cortex lesion: role of the astroglial response. Exp Neurol 194:31-42.
9. Cheng H, Guan S, Han X (2006) Abundance of triacylglycerols in ganglia and their depletion in diabetic mice: Implications for the role of altered triacylglycerols in diabetic neuropathy. J Neurochem 97:1288 -1300.
10. Cheng H, Jiang X, Han X (2007) Alterations in lipid homeostasis of mouse dorsal root ganglia induced by apolipoprotein E deficiency: a shotgun lipidomics study. J Neurochem 101:57-76.
11. Chiantia S, Kahya N, Ries J, Schwille P (2006) Effects of ceramide on liquid-ordered domains investigated by simultaneous AFM and FCS. Biophys J 90:4500-4508.
12. Chiantia S, Ries J, Chwastek G, Carrer D, Li Z, Bittman R, Schwille P (2008) Role of ceramide in membrane protein organization investigated by combined AFM and FCS. Biochim Biophys Acta 1778:1356-1364.
13. Crivello NA, Rosenberg IH, Dallal GE, Bielinski D, Joseph JA (2005) Age-related changes in neutral sphingomyelin-specific phospholipase C activity in striatum, hippocampus, and frontal cortex: implication for sensitivity to stress and inflammation. Neurochem Int 47:573-579.
14. Crutcher KA (2002) Aging and neuronal plasticity: lessons from a model. Auton Neurosci 96:25-32.
15. Cutler RG, Kelly J, Storie K, Pedersen WA, Tammara A, Hatanpaa K, Troncoso JC, Mattson MP (2004a) Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc Natl Acad Sci U S A 101:2070-2075.
16. Cutler RG, Haughey NJ, Tammara A, McArthur JC, Nath A, Reid R, Vargas DL, Pardo CA, Mattson MP (2004b) Dysregulation of sphingolipid and sterol metabolism by ApoE4 in HIV dementia. Neurology 63:626-630.
17. de Chaves EI, Bussière M, Vance DE, Campenot RB, Vance JE (1997) Elevation of ceramide within distal neurites inhibits neurite growth in cultured rat sympathetic neurons. J Biol Chem 272:3028-3035.
18. de Chaves EP, Bussiere M, MacInnis B, Vance DE, Campenot RB, Vance JE (2001) Ceramide inhibits axonal growth and nerve growth factor uptake without compromising the viability of sympathetic neurons. J Biol Chem 276:36207-36214.
19. Desai K, Sullards MC, Allegood J, Wang E, Schmelz EM, Hartl M, Humpf HU, Liotta DC, Peng Q, Merrill AH Jr (2002) Fumonisin B1 and fumonisin B1 analogs as inhibitors of ceramide synthase and inducers of apoptosis. Biochim Biophys Acta 1585:188-192.
20. Desrosiers J, Bourbonnais D, Noreau L, Rochette A, Bravo G, Bourget A (2005) Participation after stroke compared to normal aging. J Rehabil Med 37:353-357.
21. Diamond J (1982) Modeling and competition in the nervous system: clues from the sensory innervation of skin. Curr Top Dev Biol 17:147-205.
22. Diamond J, Holmes M, Coughlin M (1992a) Endogenous NGF and nerve impulses regulate the collateral sprouting of sensory axons in the skin of the adult rat. J Neurosci 12:1454-1466.
23. Diamond J, Foerster A, Holmes M, Coughlin M (1992b) Sensory nerves in adult rats regenerate and restore sensory function to the skin independently of endogenous NGF. J Neurosci 12:1467-1476.
24. Fullerton SM, Strittmatter WJ, Matthew WD (1998) Peripheral sensory nerve defects in apolipoprotein E knockout mice. Exp Neurol 153:156-163.
25. Gage FH, Björklund A, Stenevi U (1983) Reinnervation of the partially deafferented hippocampus by compensatory collateral sprouting from spared cholinergic and noradrenergic afferents. Brain Res 268:27-37.
26. Gloster A, Diamond J (1992) Sympathetic nerves in adult rats regenerate normally and restore pilomotor function during an anti-NGF treatment that prevents their collateral sprouting. J Comp Neurol 326:363-374.
27. Han X (2002) Characterization and direct quantitation of ceramide molecular species from lipid extracts of biological samples by electrospray ionization tandem mass spectrometry. Anal Biochem 302:199-212.
28. Han X (2005) Lipid alterations in the earliest clinically recognizable stage of Alzheimer's disease: implication of the role of lipids in the pathogenesis of Alzheimer's disease. Curr Alzheimer Res 2:65-77.
29. Handelmann GE, Boyles JK, Weisgraber KH, Mahley RW, Pitas RE (1992) Effects of apolipoprotein E, beta-very low density lipoproteins, and cholesterol on the extension of neurites by rabbit dorsal root ganglion neurons in vitro. J Lipid Res 33:1677-1688.
30. Hannun YA, Obeid LM (2008) Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 9:139-150.
31. Holtzman DM, Pitas RE, Kilbridge J, Nathan B, Mahley RW, Bu G, Schwartz AL (1995) Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. Proc Natl Acad Sci U S A 92:9480-9484.
32. Ignatius MJ, Gebicke-Härter PJ, Skene JH, Schilling JW, Weisgraber KH, Mahley RW, Shooter EM (1986) Expression of apolipoprotein E during nerve degeneration and regeneration. Proc Natl Acad Sci U S A 83:1125-1129.
33. Ignatius MJ, Shooter EM, Pitas RE, Mahley RW (1987) Lipoprotein uptake by neuronal growth cones in vitro. Science 236:959 -962.
34. Johnson EM Jr, Taniuchi M, Clark HB, Springer JE, Koh S, Tayrien MW, Loy R (1987) Demonstration of the retrograde transport of nerve growth factor receptor in the peripheral and central nervous system. J Neurosci 7:923-929.
35. Johnston I, Johnston LJ (2006) Ceramide promotes restructuring of model raft membranes. Langmuir 22:11284-11289.
36. Johnston I, Johnston LJ (2008) Sphingomyelinase generation of ceramide promotes clustering of nanoscale domains in supported bilayer membranes. Biochim Biophys Acta 1778:185-197.
37. Kanje M, Skottner A, Lundborg G, Sjöberg J (1991) Does insulin-like growth factor (IGF-1) trigger the cell body reaction in the rat sciatic nerve? Brain Res 563:285-287.
38. Karchewski LA, Kim FA, Johnston J, McKnight RM, Verge VM (1999) Verge, Anatomical evidence supporting the potential for modulation by multiple neurotrophins in the majority of adult lumbar sensory neurons. J Comp Neurol 413:327-341.
39. Kitatani K, Idkowiak-Baldys J, Hannun YA (2007) Mechanism of inhibition of sequestration of protein kinase C alpha /beta II by ceramide: roles of ceramide-activated protein phosphatases and phosphorylation/dephosphorylation of protein kinase C alpha /beta II on threonine 638/641. J Biol Chem 282:20647-20656.
40. Kitatani K, Idkowiak-Baldys J, Hannun YA (2008) The sphingolipid salvage pathway in ceramide metabolism and signaling. Cell Signal 20:1010-1018.
41. Lahiri DK (2004) Apolipoprotein E as a target for developing new therapeutics for Alzheimer's disease based on studies from protein, RNA, and regulatory region of the gene. J Mol Neurosci 23:225-233.
42. Lourenssen S, Motro B, Bernstein A, Diamond J (2000) Defects in sensory nerve numbers and growth in mutant Kit and Steel mice. Neuroreport 11:1159-1165.
43. Mahley RW, Weisgraber KH, Huang Y (2006) Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci U S A 103:5644-5651.
44. Masliah E, Mallory M, Veinbergs I, Miller A, Samuel W (1996) Alterations in apolipoprotein E expression during aging and neurodegeneration. Prog Neurobiol 50:493-503.
45. Mearow KM, Kril Y, Diamond J (1993) Increased NGF mRNA expression in denervated rat skin. Neuroreport 4:351-354.
46. Merrill AH Jr, van Echten G, Wang E, Sandhoff K (1993) Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ. J Biol Chem 268:27299-27306.
47. Murphy RA, Acheson A, Hodges R, Haskins J, Richards C, Reklow E, Chlumecky V, Barker PA, Alderson RF, Lindsay RM (1993) Immunological relationships of NGF, BDNF and NT3: recognition and functional inhibition by antibodies to NGF. J Neurosci 13:2853-2862.
48. Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE (1994) Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264:850-852.
49. Pertens E, Urschel-Gysbers BA, Holmes M, Pal R, Foerster A, Kril Y, Diamond J (1999) Intraspinal and behavioral consequences of nerve growth factor-induced nociceptive sprouting and nerve growth factor-induced hyperalgesia compared in adult rats. J Comp Neurol 410:73-89.
50. Piomelli D, Astarita G, Rapaka R (2007) A neuroscientist's guide to lipidomics. Nat Rev Neurosci 8:743-754.
51. Poirier J (1994) Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci 17:525-530.
52. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S (1993) Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342:697-699.
53. Popko B, Goodrum JF, Bouldin TW, Zhang SH, Maeda N (1993) Nerve regeneration occurs in the absence of apolipoprotein E in mice. J Neurochem 60:1155-1158.
54. Raivich G, Kreutzberg GW (1987) Expression of growth factor receptors in injured nervous tissue. I. Axotomy leads to a shift in the cellular distribution of specific beta-nerve growth factor binding in the injured and regenerating PNS. J Neurocytol 16:689-700.
55. Riebelin C, Futerman AH (2002) Ceramide in the regulation of neuronal development: two faces of a lipid. In: Ceramide signaling (Futerman AH, ed), pp 101-111. New York: Kluwer Academic/Plenum.
56. Scheff SW, Bernardo LS, Cotman CW (1978) Decrease in adrenergic axon sprouting in the senescent rat. Science 202:775-778.
57. Skene JH, Shooter EM (1983) Denervated sheath cells secrete a new protein after nerve injury. Proc Natl Acad Sci U S A 80:4169-4173.
58. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 90:1977-1981.
59. Szot P, White SS, Greenup JL, Leverenz JB, Peskind ER, Raskind MA (2006) Compensatory changes in the noradrenergic nervous system in the locus ceruleus and hippocampus of postmortem subjects with Alzheimer's disease and dementia with Lewy bodies. J Neurosci 26:467-478.
60. Toma JG, Rogers D, Senger DL, Campenot RB, Miller FD (1997) Spatial regulation of neuronal gene expression in response to nerve growth factor. Dev Biol 184:1-9.
61. Tsai SY, Yang LY, Wu CH, Chang SF, Hsu CY, Wei CP, Leu SJ, Liaw J, Lee YH, Tsai MD (2007) Injury-induced Janus kinase/protein kinase C-dependent phosphorylation of growth-associated protein 43 and signal transducer and activator of transcription 3 for neurite growth in dorsal root ganglion. J Neurosci Res 85:321-331.
62. Van der Zee CE, Rashid K, Le K, Moore KA, Stanisz J, Diamond J, Racine RJ, Fahnestock M (1995) Intraventricular administration of antibodies to nerve growth factor retards kindling and blocks mossy fiber sprouting in adult rats. J Neurosci 15: 5316-5323.
63. White F, Nicoll JA, Roses AD, Horsburgh K (2001) Impaired neuronal plasticity in transgenic mice expressing human apolipoprotein E4 compared to E3 in a model of entorhinal cortex lesion. Neurobiol Dis 8:611-625.
64. Yasargil GM, Macintyre L, Doucette R, Visheau B, Holmes M, Diamond J (1988) Axonal domains within shared touch domes in the rat: a comparison of their fate during conditions favoring collateral sprouting and following axonal regeneration. J Comp Neurol 270:301-312.